Podcast: Transmitted Resistance
Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

Released: January 25, 2022

Expiration: January 24, 2023

John D. Baxter
John D. Baxter, MD

Activity

Progress
1
Course Completed

In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.

Listen as he gives his perspectives on:
  • Initial response to antiretroviral therapy during primary HIV infection with baseline resistance
  • Data from the START study on treatment-naive patients with transmitted drug resistance by region and drug class
  • Recommendations from the US Department of Health and Human Services and International AIDS Society–USA guidelines on baseline genotype testing for integrase strand transfer inhibitor resistance
  • Considerations for the use of second-generation integrase strand transfer inhibitors and darunavir with transmitted drug resistance
  • Cases of transmitted multidrug-resistant HIV in patients receiving pre-exposure prophylaxis